Rheumatology Network

Continuing Coverage of ACR2014

The sessions may be finished, but information from the annual meeting of the American College of Rheumatology remains vitally important long after the last presentation has been given. Watch our ACR2014 topic center for continuing revelations from the event of the year.

Recent Content

(OPINION) A rheumatologist in solo private practice in an under-served area offers his prescription for protecting patients' interests in sound medical care as well as the time, professional obligations, and public image of physicians.

(ACR14) (VIDEO) In tests so far, the infliximab biosimilar BOW015, just approved in India, seems to look about the same to the human immune system as the original. Here, a VP of the company behind BOW015 talks about the realities of seeking approval in the US.

Two new studies say that patients' descriptions of back or hip pain may have clinically valid utiliy in diagnosis of their conditions.

Can you guess what proportion of patients in private rheumatology practices can't follow instructions for taking methotrexate? The authors of this study offer some suggestions to improve adherence.

TechTalk: In a recent Twitter exchange, rheumatologists discussed the potential of the Olloclip, a newly updated IPhone 6 lens, for on-the-spot clinical imaging.

In 96-week extension data from a Phase 3 trial the tumor necrosis factor (TNF) inhibitor shows sustained improvements in symptoms of spondyloarthropathies, with no signs of new adverse events.

(ACR2014): This member of the Rheumatology Network Editorial Board liked two promising presentations about systemic sclerosis, and another that raised some provocative questions about which doctors we like to listen to.

By clicking Accept, you agree to become a member of the UBM Medica Community.